<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27</volume><submitter>Kubi JA</submitter><pubmed_abstract>Delayed bone defect repairs lead to severe health and socioeconomic impacts on patients. Hence, there are increasing demands for medical interventions to promote bone defect healing. Recombinant proteins such as BMP-2 have been recognized as one of the powerful osteogenic substances that promote mesenchymal stem cells (MSCs) to osteoblast differentiation and are widely applied clinically for bone defect repairs. However, recent reports show that BMP-2 treatment has been associated with clinical adverse side effects such as ectopic bone formation, osteolysis and stimulation of inflammation. Here, we have identified one new osteogenic protein, named 'HKUOT-S2' protein, from &lt;i>Dioscorea opposita&lt;/i> Thunb&lt;i>.&lt;/i> Using the bone defect model, we have shown that the HKUOT-S2 protein can accele</pubmed_abstract><journal>Bioactive materials</journal><pagination>429-446</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10160600</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A new osteogenic protein isolated from &lt;i>Dioscorea opposita&lt;/i> Thunb accelerates bone defect healing through the mTOR signaling axis.</pubmed_title><pmcid>PMC10160600</pmcid><pubmed_authors>Qiao W</pubmed_authors><pubmed_authors>Brah AS</pubmed_authors><pubmed_authors>Lee KF</pubmed_authors><pubmed_authors>Sze SCW</pubmed_authors><pubmed_authors>Yeung KW</pubmed_authors><pubmed_authors>Kubi JA</pubmed_authors><pubmed_authors>Lee YL</pubmed_authors><pubmed_authors>Cheung KMC</pubmed_authors></additional><is_claimable>false</is_claimable><name>A new osteogenic protein isolated from &lt;i>Dioscorea opposita&lt;/i> Thunb accelerates bone defect healing through the mTOR signaling axis.</name><description>Delayed bone defect repairs lead to severe health and socioeconomic impacts on patients. Hence, there are increasing demands for medical interventions to promote bone defect healing. Recombinant proteins such as BMP-2 have been recognized as one of the powerful osteogenic substances that promote mesenchymal stem cells (MSCs) to osteoblast differentiation and are widely applied clinically for bone defect repairs. However, recent reports show that BMP-2 treatment has been associated with clinical adverse side effects such as ectopic bone formation, osteolysis and stimulation of inflammation. Here, we have identified one new osteogenic protein, named 'HKUOT-S2' protein, from &lt;i>Dioscorea opposita&lt;/i> Thunb&lt;i>.&lt;/i> Using the bone defect model, we have shown that the HKUOT-S2 protein can accele</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2025-04-22T00:30:26.925Z</modification><creation>2025-04-05T19:36:12.2Z</creation></dates><accession>S-EPMC10160600</accession><cross_references><pubmed>37152710</pubmed><doi>10.1016/j.bioactmat.2023.04.018</doi></cross_references></HashMap>